Obesity, aspirin, and risk of colorectal cancer in carriers of hereditary colorectal cancer: A prospective investigation in the CAPP2 study

Journal of Clinical Oncology

Volumn 33, Issue 31, 2015, Pages 3591-3597

  Movahedi, Mohammad ^a,b   Bishop, D Timothy ^b   Macrae, Finlay ^m   Mecklin, Jukka Pekka ^o   Moeslein, Gabriela ^p   Olschwang, Sylviane ^q   Eccles, Diana ^c   Evans, D Gareth ^d   Maher, Eamonn R ^e   Bertario, Lucio ^r   Bisgaard, Marie Luise ^s   Dunlop, Malcolm G ^f   Ho, Judy W C ^t   Hodgson, Shirley V ^g   Lindblom, Annika ^u   Lubinski, Jan ^v   Morrison, Patrick J ^j   Murday, Victoria ^k   Ramesar, Raj S ^w   Side, Lucy ^h   Scott, Rodney J ⁿ   Thomas, Huw J W ⁱ   Vasen, Hans F ^x   Burn, John ^l   Mathers, John C ^l   more..

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d ST MARY S HOSPITAL   (United Kingdom)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f WESTERN GENERAL HOSPITAL   (United Kingdom)

^g ST GEORGE S HOSPITAL   (United Kingdom)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ ST MARK S HOSPITAL   (United Kingdom)

^j QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^k ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^l NEWCASTLE UNIVERSITY   (United Kingdom)

^m ROYAL MELBOURNE HOSPITAL   (Australia)

ⁿ JOHN HUNTER HOSPITAL   (Australia)

^o JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^p St Josef Hospital   (Germany)

^q INSTITUT PAOLI CALMETTES   (France)

^r NATIONAL CANCER INSTITUTE   (Italy)

^s UNIVERSITY OF COPENHAGEN   (Denmark)

^t QUEEN MARY HOSPITAL   (Hong Kong)

^u KAROLINSKA INSTITUTE   (Sweden)

^v International Hereditary Cancer Centre   (Poland)

^w UNIVERSITY OF CAPE TOWN   (South Africa)

^x LEIDEN UNIVERSITY   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; STARCH; DNA BINDING PROTEIN; G-T MISMATCH-BINDING PROTEIN; MLH1 PROTEIN, HUMAN; MSH2 PROTEIN, HUMAN; MUTL PROTEIN HOMOLOG 1; NONSTEROID ANTIINFLAMMATORY AGENT; NUCLEAR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FACTORIAL DESIGN; FEMALE; FOLLOW UP; GENE MUTATION; HAZARD RATIO; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; UNDERWEIGHT; YOUNG ADULT; COLORECTAL NEOPLASMS; COMPLICATION; GENETICS; HETEROZYGOTE; INCIDENCE; MUTATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADIPOSITY; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BODY MASS INDEX; BODY WEIGHT; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; HETEROZYGOTE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MUTATION; MUTL PROTEIN HOMOLOG 1; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; OBESITY; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84947265874     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.58.9952     Document Type: Article

References (27)

1. Burn J, Gerdes AM, Macrae F, et al: Longterm effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: An analysis from the CAPP2 randomised controlled trial. Lancet 378: 2081-2087, 2011
2. World Cancer Research Fund, American Institute for Cancer Research: Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washingotn, DC, American Institute for Cancer Research, 2007
3. Kitahara CM, Berndt SI, de González AB, et al: Prospective investigation of body mass index, colorectal adenoma, and colorectal cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. J Clin Oncol 31:2450-2459, 2013
4. Ma Y, Yang Y, Wang F, et al: Obesity and risk of colorectal cancer: A systematic review of prospective studies. PloS ONE 8:e53916, 2013
5. Botma A, Nagengast FM, Braem MG, et al: Body mass index increases risk of colorectal adenomas in men with Lynch syndrome: The GEOLynch cohort study. J Clin Oncol 28:4346-4353, 2010
6. Vasen HF, Mecklin JP, Khan PM, et al: The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 34:424-425, 1991
7. Umar A, Boland CR, Terdiman JP, et al: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261-268, 2004
8. Campbell PT, Cotterchio M, Dicks E, et al: Excess body weight and colorectal cancer risk in Canada: Associations in subgroups of clinically defined familial risk of cancer. Cancer Epidemiol Biomarkers Prev 16:1735-1744, 2007
9. Win AK, Dowty JG, English DR, et al: Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genes. Br J Cancer 105:162-169, 2011
10. Ullman TA, Itzkowitz SH: Intestinal inflammation and cancer. Gastroenterology 140:1807-1816, 2011
11. Yehuda-Shnaidman E, Schwartz B: Mechanisms linking obesity, inflammation and altered metabolism to colon carcinogenesis. Obes Rev 13: 1083-1095, 2012
12. Le Chatelier E, Nielsen T, Qin J, et al: Richness of human gut microbiome correlates with metabolic markers. Nature 500:541-546, 2013
13. Smith PM, Howitt MR, Panikov N, et al: The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341:569-573, 2013
14. Burn J, Bishop DT, Mecklin J-P, et al: Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. N Engl J Med 359:2567-2578, 2008
15. Mathers JC, Movahedi M, Macrae F, et al Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: An analysis from the CAPP2 randomised controlled trial. Lancet Oncol 13:1242-1249, 2012
16. Liljegren A, Barker G, Elliott F, et al: Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: Report by the Colorectal Adenoma/Carcinoma Prevention Programme 2. J Clin Oncol 26:3434-3439, 2008
17. World Health Organization: Global database on body mass index: BMI classification. http://apps.who.int/bmi/index.jsp?introPage=intro-3.html
18. Vasen HF, Möslein G, Alonso A, et al: Guideines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 44:353-362, 2007
19. Moghaddam AA, Woodward M, Huxley R Obesity and risk of colorectal cancer: A metaanalysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev 16:2533-2547, 2007
20. Cunningham JM, Kim CY, Christensen ER, et al: The frequency of hereditary defective mis-match repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet 69:780-790, 2001
21. Slattery ML, Curtin K, Anderson K, et al: Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 92:1831-1836, 2000
22. Sinicrope FA, Foster NR, Yoon HH, et al: Association of obesity with DNA mismatch repair status and clinical outcome in patients with stage II or III colon carcinoma participating in NCCTG and NSABP adjuvant chemotherapy trials. J Clin Oncol 30:406-412, 2012
23. Campbell PT, Jacobs ET, Ulrich CM, et al: Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst 102:391-400, 2010
24. Helleman J, van Staveren IL, Dinjens WN, et al: Mismatch repair and treatment resistance in ovarian cancer. BMC Cancer 6:201, 2006
25. Kim S, Baron JA, Mott LA, et al: Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States). Cancer Causes Control 17:1299-1304, 2006
26. Neill AS, Nagle CM, Protani MM, et al: Aspirin, nonsteroidal anti-inflammatory drugs, paracetamol and risk of endometrial cancer: A case-control study, systematic review and meta-analysis. Int J Cancer 132:1146-1155, 2013
27. Lassale C, Péneau S, Touvier M, et al: Validity of web-based self-reported weight and height: Results of the Nutrinet-Santé study. J Med Internet Res 15:e152, 2013